A. Rincon

Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long‐term follow‐up study

A. Krishnan, G. Somlo, S. Forman, 2013, British journal of haematology.

A Phase 1 Trial Dose Escalation Study of Tipifarnib on a Week-On, Week-Off Schedule in Relapsed, Refractory or High-Risk Myeloid Leukemia

J. Wright, P. Frankel, S. Forman, 2011, Leukemia.

Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow Irradiation.

P. Frankel, G. Somlo, S. Forman, 2022, Transplantation and cellular therapy.

A Phase I Study of the Farnesyltransferase Inhibitor Tipifarnib in a Week- on Week-Off Dose Schedule in Acute Myelogenous Leukemia.

A. Krishnan, J. Wright, P. Frankel, 2006 .

Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long‐term follow‐up study

A. Krishnan, G. Somlo, S. Forman, 2013, British journal of haematology.